Tho V Thieu

Title: Tho V Thieu: Innovator in Pharmaceutical Chemistry

Introduction

Tho V Thieu is a notable inventor based in North Wales, Pennsylvania, recognized for his contributions to pharmaceutical chemistry. With a total of six patents to his name, Thieu has made significant advancements in the field, particularly in the development of compounds that target thromboembolic and inflammatory disorders.

Latest Patents

Among his latest patents, Thieu has developed substituted pyridine N-oxide derivatives that serve as factor XIa inhibitors. This invention provides imidazole substituted pyridine N-oxide derivatives, stereoisomers, isotopologues, isotopomers, and pharmaceutically acceptable salts. These compounds are utilized in pharmaceutical compositions aimed at treating and preventing thromboembolic disorders, inflammatory disorders, and conditions associated with plasma kallikrein activity. Another significant patent involves pyridine N-oxide derivatives, which also function as factor XIa inhibitors, further emphasizing his focus on innovative therapeutic solutions.

Career Highlights

Throughout his career, Tho V Thieu has worked with prominent companies in the pharmaceutical industry, including Cephalon, Inc. and Janssen Pharmaceutica NV. His experience in these organizations has allowed him to collaborate on various projects that have advanced medical science and improved patient outcomes.

Collaborations

Some of Thieu's notable coworkers include Karen L. Milkiewicz and Henry Joseph Breslin, who have contributed to his research and development efforts in the pharmaceutical field.

Conclusion

Tho V Thieu's work in developing innovative pharmaceutical compounds has made a significant impact on the treatment of various medical conditions. His patents reflect a commitment to advancing healthcare through scientific innovation.